Unternehmen PEPTOMYC SL PEPTOMYC SL Passend zu diesem Beitrag Forschungsprojekte 1 Verknüpfungen FIRST-IN-CLASS MYC INHIBITOR: THE MAKING OF A BREAKTHROUGH CANCER THERAPY Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers, with very few and often ineffectiv… →